| Literature DB >> 27000064 |
Fei Wang1, Xiaohan Lu2, Kexin Peng2, Hui Fang3, Li Zhou3, Jiahui Su3, Adam Nau2, Kevin T Yang2, Atsuhiro Ichihara4, Aihua Lu3, Shu-Feng Zhou5, Tianxin Yang6.
Abstract
Within the kidney, the (pro)renin receptor (PRR) is predominantly expressed in the collecting duct (CD), particularly in intercalated cells, and it is regulated by the PGE2 receptor EP4 Notably, EP4 also controls urinary concentration through regulation of aquaporin 2 (AQP2). Here, we tested the hypothesis that sequential activation of EP4 and PRR determines AQP2 expression in the CD, thus mediating the antidiuretic action of vasopressin (AVP). Water deprivation (WD) elevated renal PRR expression and urinary soluble PRR excretion in rats. Intrarenal infusion of a PRR decoy peptide, PRO20, or an EP4 antagonist partially prevented the decrease in urine volume and the increase in urine osmolality and AQP2 expression induced by 48-hour WD. In primary cultures of rat inner medullary CD cells, AQP2 expression induced by AVP treatment for 24 hours depended on sequential activation of the EP4 receptor and PRR. Additionally, mice lacking PRR in the CD exhibited increased urine volume and decreased urine osmolality under basal conditions and impaired urine concentrating capability accompanied by severe volume loss and a dangerous level of plasma hyperosmolality after WD. Together, these results suggest a previously undescribed linear AVP/PGE2/EP4/PRR pathway in the CD for regulation of AQP2 expression and urine concentrating capability.Entities:
Keywords: (Pro)renin receptor; aquaporin-2; nephrogenic diabetes insipidus; prostaglandin EP4 receptor; vasopressin
Mesh:
Substances:
Year: 2016 PMID: 27000064 PMCID: PMC5042659 DOI: 10.1681/ASN.2015050592
Source DB: PubMed Journal: J Am Soc Nephrol ISSN: 1046-6673 Impact factor: 10.121